In our latest podcast, Dr. Lui Franciosi has chops in the pharma game, but the collection of professors emeritus, leaders in biochemistry, cancer research gods, and generally cleverer-than-me smartypants’ he’s put together at Veritas Phrama (VRT.C) is something to behold.

Their plan: Do clinical research on medical marijuana in a way nobody has done before, and find exactly which strain (or strains, or combos of strains) are the best at treating pain, nausea and vomiting – specifically as it relates to cancer patients.

It’s not often a Canadian junior markets CEO can say he cures cancer, but Franciosi is at least in the ballpark.

FULL DISCLOSURE: Veritas Pharmaceuticals is a marketing consulting client of Equity.Guru.

Written By:

Chris Parry

A multi-Webster Award winner for excellence in BC journalism, Parry is the founder and publisher of Equity.Guru, which he built with the specific plan to blend old school reporting with stock promotion, in a way that puts the emphasis on truth, high standards, and ethics. Parry is a veteran of TV, radio, and print, and consults with public companies to help them figure out their storylines, lay down achievable milestones, and improve their communication with shareholders, while also posting regular deep dive analysis of companies in the public spotlight.

More By This Author